Molecular Pathology Tests: Comments Needed on Fee Schedule Options

The Centers for Medicare & Medicaid Services (CMS) issued on July 6, 2012, a proposed rule on payment policies and rates under the Medicare Physician Fee Schedule for calendar year 2013.    The proposed rule requests public comments on the payment schedule to be used for advanced diagnostic molecular pathology services.  CMS is interested in comments on whether molecular pathology tests should be paid under the Clinical Laboratory Fee Schedule or through the Physician Fee Schedule